Adgero Biopharmaceuticals Holdings Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile.
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Adgero Biopharmaceuticals Holdings Inc (Adgero) is a biopharmaceutical company which advances its proprietary late stage photodynamic therapy (PDT) for the treatment of unmet clinical needs of patients with cutaneous metastatic breast cancer (CMBC) and bile duct cancer. Its PDT is a treatment utilizes light sensitive compounds which act as catalyst to produce a form of oxygen that induces local tumor cell death when exposed to specific wavelengths of light. The companys lead pipeline candidate, REM-001 therapy, consists of a light delivery device; a laser light source, and the drug REM-001. It is also investigating REM-001 as follow on indication for Cutaneous Metastatic Cancers of Lung, Colon, and Ovary. Adgero is headquartered in Princeton Junction, New Jersey, the US.
Adgero Biopharmaceuticals Holdings Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Adgero Biopharmaceuticals Holdings Inc (Adgero) is a biopharmaceutical company which advances its proprietary late stage photodynamic therapy (PDT) for the treatment of unmet clinical needs of patients with cutaneous metastatic breast cancer (CMBC) and bile duct cancer. Its PDT is a treatment utilizes light sensitive compounds which act as catalyst to produce a form of oxygen that induces local tumor cell death when exposed to specific wavelengths of light. The companys lead pipeline candidate, REM-001 therapy, consists of a light delivery device; a laser light source, and the drug REM-001. It is also investigating REM-001 as follow on indication for Cutaneous Metastatic Cancers of Lung, Colon, and Ovary. Adgero is headquartered in Princeton Junction, New Jersey, the US.
Adgero Biopharmaceuticals Holdings Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
2
List of Tables 3
List of Figures 4
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Adgero Biopharma Acquires Certain Assets and Regulatory Filings from Miravant Medical Technologies 10
Venture Financing 10
Adgero Biopharma Raises USD0.5 Million in Venture Financing 10
Adgero Biopharma Raises USD3 Million Financing 11
Adgero Biopharma Raises Funds through Venture Financing 12
Equity Offering 12
Adgero Biopharma Raises USD2 Million in Equity Financing 12
Adgero Biopharma to Raise Funds in Private Placement of Shares and Warrants 13
Adgero Biopharma Raises USD2 Million in Private Placement of Shares 14
Adgero Biopharma Raises USD9.7 Million in Equity Financing 15
Debt Offering 15
Adgero Biopharma Raises USD0.3 Million in Private Placement of 6% Notes Due 2016 15
Adgero Biopharma Raises Funds in Private Placement of 6% Notes Due 2016 16
Adgero Biopharma Raises Funds in Private Placement of 6% Notes Due 2016 17
Adgero Biopharmaceuticals Holdings Inc - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Feb 14, 2017: Adgero Biopharmaceuticals Holdings, Inc. Expands Executive Management Team with Appointment of Jane M. Maida as Chief Financial Officer 21
Product News 22
Sep 27, 2016: Adgero Biopharmaceuticals to Present at the Fifth Annual OktoberINVESTfest, US - Bavaria, Germany Investors Conference in New York 22
May 03, 2016: Adgero Biopharmaceuticals to Present at the Joseph Gunnar Pioneers 2016 Conference 23
Jan 26, 2017: Adgero Biopharmaceuticals to Present at Noble Capital Markets Thirteenth Annual Investor Conference 24
Jan 14, 2016: Adgero Biopharmaceuticals to Present at Noble Financial Capital Markets 12th Annual Investor Conference on January 18, 2016 25
Jan 05, 2016: Adgero Biopharmaceuticals to Present at Biotech Showcase on January 11, 2016 26
Clinical Trials 27
Apr 10, 2017: Positive Clinical Data of Adgero Biopharmaceuticals REM-001 Therapy for the Treatment of Cutaneous Metastatic Breast Cancer Presented at 37th ASLMS Annual Conference 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28
List Of Tables
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Key Facts 1
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Adgero Biopharmaceuticals Holdings Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Adgero Biopharma Acquires Certain Assets and Regulatory Filings from Miravant Medical Technologies 10
Adgero Biopharma Raises USD0.5 Million in Venture Financing 10
Adgero Biopharma Raises USD3 Million Financing 11
Adgero Biopharma Raises Funds through Venture Financing 12
Adgero Biopharma Raises USD2 Million in Equity Financing 12
Adgero Biopharma to Raise Funds in Private Placement of Shares and Warrants 13
Adgero Biopharma Raises USD2 Million in Private Placement of Shares 14
Adgero Biopharma Raises USD9.7 Million in Equity Financing 15
Adgero Biopharma Raises USD0.3 Million in Private Placement of 6% Notes Due 2016 15
Adgero Biopharma Raises Funds in Private Placement of 6% Notes Due 2016 16
Adgero Biopharma Raises Funds in Private Placement of 6% Notes Due 2016 17
Adgero Biopharmaceuticals Holdings Inc, Key Competitors 18
Adgero Biopharmaceuticals Holdings Inc, Key Employees 19
List Of Figures
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Adgero Biopharmaceuticals Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
RELATED REPORTS
SAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
